California researchers found that analyzing cell-bound complement activation products (CB-CAPs) ably distinguishes between systemic lupus erythematosus (SLE) and fibromyalgia (FM), and complements current test methods. Whereas fibromyalgia and lupus might share non-specific symptoms, the ... Read more